Clinical Trial: Alwide Plus China Post-market Clinical Investigation

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304427) titled 'Alwide Plus China Post-market Clinical Investigation' on Dec. 01.

Brief Summary: This is a prospective, single-arm, multi-center, post-market registry study conducted in China. The purpose is to evaluate the safety and effectiveness of the AlwideTM Plus balloon catheter for pre-dilatation of the aortic valve during TAVR in the real-world setting.

Study Start Date: Jan. 03

Study Type: OBSERVATIONAL

Condition: Severe Aortic Stenosis Transcatheter Aortic Valve Replacemen

Recruitment Status: COMPLETED

Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Disclaimer: Curated by HT Syndication....